What Happened?
Los Angeles, CA-based ChromaDex Promoted Brianna Gerber as Chief Financial Officer
About the Company
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.
About the Person
Brianna Gerber is Chief Financial Officer at ChromaDex. Previously, Brianna held various senior HR leadership roles in the industry.
Info Source
News
Short Profile